How to manage mitral stenosis in a pregnant patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Mitral Stenosis in Pregnancy

Pre-Pregnancy Evaluation and Intervention

All women with suspected mitral stenosis must undergo clinical evaluation and transthoracic echocardiography before attempting pregnancy, and those with severe disease (mitral valve area ≤1.5 cm²) should have valve intervention performed before conception. 1

Pre-Pregnancy Risk Stratification

  • Pregnancy should be strongly discouraged in women with severe mitral stenosis (MVA ≤1.5 cm²), especially if MVA <1.0 cm², until definitive intervention is performed. 1
  • Up to 74% of patients with severe mitral stenosis experience clinical deterioration during pregnancy, with fetal mortality reaching 30% if severe symptoms develop. 1
  • Exercise testing is reasonable in asymptomatic women with severe mitral stenosis who are considering pregnancy to unmask symptoms. 1

Pre-Pregnancy Intervention Strategy

  • Percutaneous mitral balloon commissurotomy (PMBC) is recommended before pregnancy for all symptomatic patients with severe mitral stenosis (MVA ≤1.5 cm²). 1
  • PMBC is also recommended before pregnancy for asymptomatic patients with severe mitral stenosis who have favorable valve morphology (minimal calcification, good leaflet mobility, minimal subvalvular disease). 1
  • Pre-pregnancy counseling by a cardiologist with expertise in valvular disease during pregnancy is mandatory for all women with severe mitral stenosis. 1

Management During Pregnancy

Monitoring and Multidisciplinary Care

All pregnant patients with severe mitral stenosis (stages C and D) must be monitored in a tertiary care center with a dedicated Heart Valve Team including cardiologists, cardiac surgeons, anesthesiologists, and high-risk obstetricians. 1

Medical Management Algorithm

Step 1: Beta-Blocker Therapy for Heart Rate Control

  • Beta-blockers are the cornerstone of medical therapy and should be initiated for heart rate control in all pregnant patients with mitral stenosis. 1
  • Metoprolol is preferred over atenolol due to lower incidence of fetal growth retardation. 1
  • Target heart rate should minimize transmitral gradient while maintaining adequate cardiac output. 1
  • Digoxin may be added for additional rate control if atrial fibrillation develops. 1

Step 2: Activity Restriction

  • Bed rest and restricted physical activity after the first trimester help with heart rate control and reduce hemodynamic stress. 1

Step 3: Diuretic Therapy (Use with Caution)

  • Diuretics are reasonable for symptomatic relief if pulmonary congestion develops, but must be used cautiously to avoid reducing placental perfusion. 1, 2

Step 4: Anticoagulation (If Indicated)

  • Anticoagulation should be considered for women with atrial fibrillation. 1
  • Anticoagulation should also be considered for women in sinus rhythm with very severe left atrial dilatation, spontaneous echo contrast, or heart failure. 1

Critical Contraindications

ACE inhibitors and ARBs are absolutely contraindicated during pregnancy due to fetal toxicity including renal dysplasia, oligohydramnios, growth retardation, and intrauterine fetal death. 1

Indications for Percutaneous Mitral Balloon Commissurotomy During Pregnancy

Strict Criteria for Intervention

PMBC during pregnancy is indicated ONLY when ALL of the following criteria are met: 1, 2

  1. Severe mitral stenosis (MVA ≤1.5 cm²) 1, 2
  2. Persistent NYHA class III-IV heart failure symptoms despite optimal medical therapy (beta-blockers, diuretics, activity restriction) 1, 2
  3. Favorable valve morphology (minimal calcification, good leaflet mobility, minimal subvalvular disease) 1, 2
  4. Gestational age preferably >20 weeks (safest period for fetus) 1, 2

When PMBC Should NOT Be Performed

PMBC is NOT recommended prophylactically or in patients with severe mitral stenosis who have good functional tolerance without pulmonary hypertension. 1, 2

Procedural Considerations for PMBC During Pregnancy

Center and Operator Requirements

PMBC must be performed only in highly experienced centers with operators who have demonstrated low complication rates in pregnant patients. 1, 2

Technical Approach

  • The Inoue balloon technique is preferred as it keeps the procedure as short as possible. 1, 2
  • Radiation exposure must be minimized by abdominal shielding and omitting hemodynamic measurements and angiography when possible. 1, 2
  • Continuous fetal monitoring should be performed throughout the procedure. 2
  • Backup cardiac surgery, anesthesiology, and high-risk obstetrics services must be immediately available. 2

Expected Outcomes from Research Studies

  • Mitral valve area typically increases from 0.8-1.2 cm² to 1.7-2.0 cm² post-procedure. 3, 4
  • Mean mitral gradient decreases from 15-18 mmHg to 5-7 mmHg. 3, 4
  • Immediate symptomatic improvement by at least one NYHA functional class occurs in all patients. 3, 4
  • Normal term vaginal deliveries occur in the majority of cases after successful PMBC. 3, 4

Procedural Risks

  • 5% risk of severe traumatic mitral regurgitation requiring emergency surgery under cardiopulmonary bypass, which is particularly dangerous for the fetus. 1, 2
  • Very low risk (<1%) of cardiac tamponade or embolic events. 1, 2
  • No increased risk of abortion or preterm delivery when performed after 20 weeks. 5, 3

Management of Unfavorable Valve Anatomy

For patients with severe leaflet calcification, thickening, immobility, or commissural calcification who have refractory NYHA class IV symptoms despite medical therapy, valve intervention is reasonable only as a life-saving measure. 1, 2

Surgical Considerations

  • Open heart surgery during pregnancy carries a 15-30% fetal mortality rate and should be restricted to rare conditions that threaten the mother's life. 1, 2
  • Valve operations should NOT be performed in pregnant patients with mitral stenosis in the absence of severe (NYHA class IV) heart failure symptoms. 1
  • If surgery becomes absolutely necessary, it should be performed with high pump flows, normothermic perfusion, shortest possible pump time, and continuous fetal monitoring. 2

Delivery Planning

Mode of Delivery

  • Vaginal delivery under epidural anesthesia is preferred and well-tolerated in most patients with mitral stenosis, even those who experienced transient heart failure during pregnancy. 1, 6
  • Cesarean section is recommended for patients with severe mitral stenosis or severe pulmonary hypertension, as well as women on oral anticoagulants in pre-term labor when there is risk to the mother's life. 1

Peripartum Hemodynamic Management

  • Heart rate control is crucial during labor and delivery, as tachycardia dramatically increases transmitral gradient. 1
  • Careful fluid management is essential to avoid pulmonary edema while maintaining adequate cardiac output. 1
  • The immediate postpartum period is particularly high-risk due to abrupt increase in preload from autotransfusion and aortocaval decompression. 6

Common Pitfalls to Avoid

  1. Delaying PMBC in symptomatic patients: Waiting too long increases risk of maternal and fetal complications; intervention should be performed promptly once medical therapy fails. 2, 3

  2. Performing PMBC prophylactically: This exposes mother and fetus to unnecessary procedural risks when medical management is adequate. 1, 2

  3. Using ACE inhibitors or ARBs: These are teratogenic and absolutely contraindicated throughout pregnancy. 1

  4. Aggressive diuresis: Excessive diuretic use can compromise placental perfusion and fetal growth. 1

  5. Attempting PMBC in unfavorable anatomy: This significantly increases the 5% baseline risk of severe mitral regurgitation requiring emergency surgery. 2

  6. Inadequate heart rate control: Tachycardia doubles or triples the transmitral gradient, precipitating pulmonary edema. 1

Rheumatic Heart Disease Prophylaxis

In patients with rheumatic mitral stenosis, long-term secondary prophylaxis against rheumatic fever is recommended throughout pregnancy and beyond. 1

  • For severe rheumatic heart disease: minimum 10 years after most recent acute rheumatic fever, or until 40 years of age (whichever is longer). 1
  • Prevention aims at preventing recurrent group A streptococcal infections. 1

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

2
Guideline

Balloon Mitral Valvuloplasty in Second Trimester Pregnancy with Severe Mitral Stenosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3
Research

Balloon mitral valvuloplasty during pregnancy--our experience.

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology, 2002

Related Questions

What is the management of mitral valve stenosis in pregnancy?
When is a pregnant patient with severe mitral stenosis most likely to decompress?
What physiologic change places a patient with mitral stenosis secondary to rheumatic heart disease at risk for the development of heart failure during pregnancy?
What physiologic change places a pregnant patient with mitral stenosis at risk for the development of heart failure during pregnancy?
What is the inotropic agent of choice for hypotension in severe Mitral Stenosis (mitral valve narrowing) during pregnancy?
Does the Atherosclerotic Cardiovascular Disease (ASCVD) risk assessment determine both the Hypertension (HTN) medication regimen and the cholesterol medication regimen, or only the cholesterol medication regimen?
What is the medical term for pain in the fifth toe?
What are the recent guidelines for managing hypertension in a general adult population?
What are the recommended initial steps for a patient with right low back pain radiating down the thigh?
What are the latest guidelines for managing patients with ST-Elevation Myocardial Infarction (STEMI) or Non-ST-Elevation Myocardial Infarction (NSTEMI)?
How often should activated partial thromboplastin time (aPTT) be checked in a patient on heparin (unfractionated heparin) with impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question